Interestingly, a recent study has been suggested that leptin activates SREBP‐2 and thereby promotes migration and invasion of breast cancer cells via upregulation of acetyl‐CoA acetyltransferase 2 (ACAT2) [38]. Here, LEP is linked to breast carcinoma.